AblaCor Medical Corporation

Website http://www.ablacor.com

Founded 2013

Employees 6

Follow

Overview

AblaCor's mission is to develop a catheter ablation system that will significantly advance the treatment of atrial fibrillation (AF), the most common irregular heart rhythm. AblaCor’s CircumBlator™ system will enable a procedure that offers a low complication rate, shorter procedure times, and fewer repeat procedures. AblaCor’s competitive advantage is controlled contact with the heart tissue to provide consistent, continuous ablations.

Video Pitch

Management Team

President/Founder

Martin Sklar

Martin is an entrepreneur, leader, and engineer with >25 years experience in business development and project management of successful medical products with revenues >$1B. He successfully led development of image-guided surgery, automated clinical analyzers, orthopedics, pain management, and drug delivery products. Martin was a founder and first president of the Medical Development Group, an industry organization for med-tech professionals.

Director, Strategic Management

Joyce College

Joyce demonstrates leadership in strategic planning, clinical marketing, product management, and commercialization. She has a passion for innovation and the value it brings to patients, clinicians and the healthcare system. She was a product/program manager for Fresenius Medical Care where she led the launch of several treatments and diagnostic testing for renal patients including the drug, Epogen®.

Commercialization

Roy Wallen

Roy has served in leadership roles for start-up, mid-range, and global companies. His expertise is in bringing new medical technologies out of the laboratory and into clinical use with demonstrated commercial success. In addition to successful launches in the United States, Roy has successfully launched several new products in Europe and Japan; supported, built, and maintained distribution channels; and established a local market presence.

Director

Jim Bricker

Jim has served as President & CEO of six high tech companies, two of which he founded, and as a business consultant, aiding start-ups in the business planning and fundraising stages. He has successfully engaged individual investors, Angel groups, and Venture Capital groups in his companies. He holds two Bachelor’s degrees from M.I.T.: a B.S. in Mechanical Engineering and a B.S. in Management; as well as an MBA from the Harvard Business School.

Director

Robert Flaherty

Bob was Pres. & CEO of Athena Diagnostics of Thermo Fisher Scientific, Inc., with $100M+ in revenue and $55M in EBITDA. He was President of Becton Dickinson Medical and Vacutainer Systems of Becton Dickinson & Comp. . He served on the Boards of Datatrak Int'l, AngioDynamics, Xtent, Repromedix, all on NASDAQ as well as Synthes, now part of J&J. He has a B.S. in Industrial Engineering from Lehigh University and an MBA from Harvard Business School.

Clinical & Regulatory Consultant

Michael Drues, Ph.D.

Dr. Drues consults to the U.S. Food and Drug Administration (FDA), Health Canada, the US and European Patent Offices, the Centers for Medicare and Medicaid Services (CMS) and other regulatory and governmental agencies around the world. He conducts seminars and short courses for medical device, pharmaceutical & biotechnology companies, FDA, Health Canada, US & European Patent Offices, CMS and other worldwide regulatory & governmental agencies.